Randomized Trial to Test a Chemo-Mechanical Antiplaque Regimen as Adjunct to Periodontal Therapy

The control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have difficulty achieving optimal plaque control. Subjects with diabetes, in which immune and wound-healing responses are typically impaired, may benefit f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JDR clinical and translational research Jg. 9; H. 2; S. 160
Hauptverfasser: Li, L, Hayashi-Okada, Y, Falkner, K L, Cervi, S, Andrusz, S, Shimizu, Y, Zambon, J J, Kirkwood, K L, Schifferle, R E, Diaz, P I
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.04.2024
Schlagworte:
ISSN:2380-0852, 2380-0852
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have difficulty achieving optimal plaque control. Subjects with diabetes, in which immune and wound-healing responses are typically impaired, may benefit from intensive antiplaque control regimens after scaling and root planing (SRP). This study aimed to evaluate the effects of an intensive, at-home, chemical, and mechanical antiplaque regimen as an adjunct to SRP for the treatment of moderate to severe periodontitis. A secondary objective was to compare responses in subjects with type 2 diabetes and nondiabetics. This was a 6-mo, single-center, parallel-group, randomized trial. The test group received SRP and oral hygiene instructions, and subjects were instructed to use a 0.12% chlorhexidine gluconate mouthrinse twice a day for 3 mo and utilize rubber interproximal bristle cleaners twice a day for 6 mo. The control group received SRP and oral hygiene instructions. The main outcome was change in mean probing depth (PD) from baseline to 6 mo. Secondary outcomes included change in sites with deep PDs, mean clinical attachment level, bleeding on probing, plaque index, hemoglobin A1C, fasting blood glucose, C-reactive protein, and taste assessment. This study was registered at ClinicalTrials.gov as NCT04830969. In total, 114 subjects were randomized to either treatment. Eighty-six subjects completed the trial with no missing visits. Neither an intention-to-treat nor a per-protocol analysis showed statistically significant differences between treatment groups in mean PD at 6 mo. In a subgroup analysis, subjects with diabetes in the test group showed a statistically significant greater reduction in mean PD at 6 mo when compared to subjects with diabetes receiving the control treatment (Δ = 0.15, = 0.04), while there were no differences within nondiabetics (Δ = 0.02, = 0.75). Outcomes in subjects with diabetes may be improved by chemo-mechanical antiplaque measures after nonsurgical periodontal therapy.
AbstractList The control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have difficulty achieving optimal plaque control. Subjects with diabetes, in which immune and wound-healing responses are typically impaired, may benefit from intensive antiplaque control regimens after scaling and root planing (SRP). This study aimed to evaluate the effects of an intensive, at-home, chemical, and mechanical antiplaque regimen as an adjunct to SRP for the treatment of moderate to severe periodontitis. A secondary objective was to compare responses in subjects with type 2 diabetes and nondiabetics. This was a 6-mo, single-center, parallel-group, randomized trial. The test group received SRP and oral hygiene instructions, and subjects were instructed to use a 0.12% chlorhexidine gluconate mouthrinse twice a day for 3 mo and utilize rubber interproximal bristle cleaners twice a day for 6 mo. The control group received SRP and oral hygiene instructions. The main outcome was change in mean probing depth (PD) from baseline to 6 mo. Secondary outcomes included change in sites with deep PDs, mean clinical attachment level, bleeding on probing, plaque index, hemoglobin A1C, fasting blood glucose, C-reactive protein, and taste assessment. This study was registered at ClinicalTrials.gov as NCT04830969. In total, 114 subjects were randomized to either treatment. Eighty-six subjects completed the trial with no missing visits. Neither an intention-to-treat nor a per-protocol analysis showed statistically significant differences between treatment groups in mean PD at 6 mo. In a subgroup analysis, subjects with diabetes in the test group showed a statistically significant greater reduction in mean PD at 6 mo when compared to subjects with diabetes receiving the control treatment (Δ = 0.15, = 0.04), while there were no differences within nondiabetics (Δ = 0.02, = 0.75). Outcomes in subjects with diabetes may be improved by chemo-mechanical antiplaque measures after nonsurgical periodontal therapy.
The control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have difficulty achieving optimal plaque control. Subjects with diabetes, in which immune and wound-healing responses are typically impaired, may benefit from intensive antiplaque control regimens after scaling and root planing (SRP).BACKGROUNDThe control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have difficulty achieving optimal plaque control. Subjects with diabetes, in which immune and wound-healing responses are typically impaired, may benefit from intensive antiplaque control regimens after scaling and root planing (SRP).This study aimed to evaluate the effects of an intensive, at-home, chemical, and mechanical antiplaque regimen as an adjunct to SRP for the treatment of moderate to severe periodontitis. A secondary objective was to compare responses in subjects with type 2 diabetes and nondiabetics.OBJECTIVESThis study aimed to evaluate the effects of an intensive, at-home, chemical, and mechanical antiplaque regimen as an adjunct to SRP for the treatment of moderate to severe periodontitis. A secondary objective was to compare responses in subjects with type 2 diabetes and nondiabetics.This was a 6-mo, single-center, parallel-group, randomized trial. The test group received SRP and oral hygiene instructions, and subjects were instructed to use a 0.12% chlorhexidine gluconate mouthrinse twice a day for 3 mo and utilize rubber interproximal bristle cleaners twice a day for 6 mo. The control group received SRP and oral hygiene instructions. The main outcome was change in mean probing depth (PD) from baseline to 6 mo. Secondary outcomes included change in sites with deep PDs, mean clinical attachment level, bleeding on probing, plaque index, hemoglobin A1C, fasting blood glucose, C-reactive protein, and taste assessment. This study was registered at ClinicalTrials.gov as NCT04830969.METHODSThis was a 6-mo, single-center, parallel-group, randomized trial. The test group received SRP and oral hygiene instructions, and subjects were instructed to use a 0.12% chlorhexidine gluconate mouthrinse twice a day for 3 mo and utilize rubber interproximal bristle cleaners twice a day for 6 mo. The control group received SRP and oral hygiene instructions. The main outcome was change in mean probing depth (PD) from baseline to 6 mo. Secondary outcomes included change in sites with deep PDs, mean clinical attachment level, bleeding on probing, plaque index, hemoglobin A1C, fasting blood glucose, C-reactive protein, and taste assessment. This study was registered at ClinicalTrials.gov as NCT04830969.In total, 114 subjects were randomized to either treatment. Eighty-six subjects completed the trial with no missing visits. Neither an intention-to-treat nor a per-protocol analysis showed statistically significant differences between treatment groups in mean PD at 6 mo. In a subgroup analysis, subjects with diabetes in the test group showed a statistically significant greater reduction in mean PD at 6 mo when compared to subjects with diabetes receiving the control treatment (Δ = 0.15, P = 0.04), while there were no differences within nondiabetics (Δ = 0.02, P = 0.75).RESULTSIn total, 114 subjects were randomized to either treatment. Eighty-six subjects completed the trial with no missing visits. Neither an intention-to-treat nor a per-protocol analysis showed statistically significant differences between treatment groups in mean PD at 6 mo. In a subgroup analysis, subjects with diabetes in the test group showed a statistically significant greater reduction in mean PD at 6 mo when compared to subjects with diabetes receiving the control treatment (Δ = 0.15, P = 0.04), while there were no differences within nondiabetics (Δ = 0.02, P = 0.75).Outcomes in subjects with diabetes may be improved by chemo-mechanical antiplaque measures after nonsurgical periodontal therapy.CONCLUSIONOutcomes in subjects with diabetes may be improved by chemo-mechanical antiplaque measures after nonsurgical periodontal therapy.This study suggests diabetic subjects may benefit from an intensive, at-home, chemical, and mechanical antiplaque regimen to improve nonsurgical periodontal therapy outcomes.KNOWLEDGE TRANSFER STATEMENT This study suggests diabetic subjects may benefit from an intensive, at-home, chemical, and mechanical antiplaque regimen to improve nonsurgical periodontal therapy outcomes.
Author Zambon, J J
Kirkwood, K L
Schifferle, R E
Andrusz, S
Shimizu, Y
Li, L
Hayashi-Okada, Y
Cervi, S
Diaz, P I
Falkner, K L
Author_xml – sequence: 1
  givenname: L
  surname: Li
  fullname: Li, L
  organization: Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 2
  givenname: Y
  surname: Hayashi-Okada
  fullname: Hayashi-Okada, Y
  organization: Sunstar Inc., Osaka, Japan
– sequence: 3
  givenname: K L
  surname: Falkner
  fullname: Falkner, K L
  organization: UB Microbiome Center, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 4
  givenname: S
  surname: Cervi
  fullname: Cervi, S
  organization: UB Microbiome Center, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 5
  givenname: S
  surname: Andrusz
  fullname: Andrusz, S
  organization: UB Microbiome Center, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 6
  givenname: Y
  surname: Shimizu
  fullname: Shimizu, Y
  organization: Sunstar Inc., Osaka, Japan
– sequence: 7
  givenname: J J
  surname: Zambon
  fullname: Zambon, J J
  organization: Department of Periodontics and Endodontics, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 8
  givenname: K L
  orcidid: 0000-0003-4519-8973
  surname: Kirkwood
  fullname: Kirkwood, K L
  organization: Department of Head and Neck/Plastic and Reconstructive Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
– sequence: 9
  givenname: R E
  surname: Schifferle
  fullname: Schifferle, R E
  organization: Department of Periodontics and Endodontics, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY, USA
– sequence: 10
  givenname: P I
  orcidid: 0000-0002-9501-1145
  surname: Diaz
  fullname: Diaz, P I
  organization: Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37148266$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtPwzAQhC1UREvpD-CCfOQS8COxnWNV8ZJAoCqcg2tvqKvEDnFyKL-eVBSJ04x2vl2t5hxNfPCA0CUlN5RKecu4IkSlKeOUCklEdoJmh1lCVMYm__wULWLcEUKo4FJm_AxNuaSpYkLM0Mdaexsa9w0WF53TNe4DLiD2WOPVFpqQvIDZau_MGC1979pafw2A1_DpGvBYR7y0u8Gb_rD4Bp0LNvh-hIstdLrdX6DTStcRFkedo_f7u2L1mDy_Pjytls-J4SnpEwsVFZlRNrVUkhyU4VzlG0qMFHmuK0FZXmVSAa8s1VRXkihQubUp1TZVgs3R9e_dtgvjg7EvGxcN1LX2EIZYMkVJzgjL5IheHdFh04At2841utuXf62wH9eQZnk
CitedBy_id crossref_primary_10_1007_s42399_025_01784_9
crossref_primary_10_1002_JPER_24_0141
crossref_primary_10_1007_s13340_025_00805_1
crossref_primary_10_62838_ASMJ_2025_1_02
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/23800844231167065
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Dentistry
EISSN 2380-0852
ExternalDocumentID 37148266
Genre Randomized Controlled Trial
Journal Article
GroupedDBID .2E
.2J
.2N
0R~
1~K
31R
31U
31X
31Z
54M
AABOD
AACMV
AACTG
AAEWN
AAGLT
AAGMC
AAKGS
AAPII
AAQXI
AARIX
AATAA
AATBZ
AAUAS
ABAWP
ABCCA
ABCJG
ABIDT
ABJZC
ABLUO
ABPNF
ABQXT
ABRHV
ABUJY
ABVFX
ACARO
ACDXX
ACFEJ
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLZU
ACOXC
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADNON
ADRRZ
ADVBO
AECGH
AEDTQ
AEILP
AEKYL
AEPTA
AESZF
AEWDL
AEWHI
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AJGYC
AJUZI
AJVBE
AJXAJ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ARTOV
AUTPY
AYAKG
B3H
B8R
B8Z
B94
BBRGL
BDDNI
BKIIM
BKSCU
BPACV
BSEHC
BWJAD
BYIEH
CGR
CUY
CVF
DB0
DF0
DO-
DV7
EBS
ECM
EIF
EJD
FHBDP
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
J8X
K.F
NPM
O9-
Q7L
Q7U
Q83
ROL
SASJQ
SAUOL
SCNPE
SFC
SGO
SGR
SGV
SGZ
SHG
SPQ
SPV
ZONMY
ZPPRI
ZRKOI
ZSSAH
7X8
AJHME
ID FETCH-LOGICAL-c340t-def165c8d4d1709e8c3389b10c7699af6129f578e3fd1a1af708e89dd41ad4862
IEDL.DBID 7X8
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000982118300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2380-0852
IngestDate Thu Oct 02 10:00:17 EDT 2025
Mon Jul 21 05:58:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords type 2 diabetes, scaling and root planing, adjuncts
interproximal rubber cleaners
chlorhexidine
nonsurgical periodontal therapy
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c340t-def165c8d4d1709e8c3389b10c7699af6129f578e3fd1a1af708e89dd41ad4862
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0003-4519-8973
0000-0002-9501-1145
PMID 37148266
PQID 2810920257
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2810920257
pubmed_primary_37148266
PublicationCentury 2000
PublicationDate 2024-Apr
20240401
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-Apr
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JDR clinical and translational research
PublicationTitleAlternate JDR Clin Trans Res
PublicationYear 2024
SSID ssj0001637753
Score 2.2724056
Snippet The control of dental biofilm regrowth after nonsurgical periodontal therapy is associated with better clinical outcomes. However, many patients have...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 160
SubjectTerms Chronic Periodontitis - drug therapy
Dental Scaling - methods
Diabetes Mellitus, Type 2 - drug therapy
Glycated Hemoglobin
Humans
Root Planing - methods
Title Randomized Trial to Test a Chemo-Mechanical Antiplaque Regimen as Adjunct to Periodontal Therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/37148266
https://www.proquest.com/docview/2810920257
Volume 9
WOSCitedRecordID wos000982118300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qBb34ftQXEbwGk93sJjlJUYsHW0qp0ltNk6wouFtt9eCvd2Z3S0-C4GUXFsKGySTzzSPfEHIRIQGMyiwTqZdMOp0x60zE4rFViQmSyzLg9nivul09HJpeHXCb1mWV8zOxPKh94TBGfhlpwQ146om6mrwz7BqF2dW6hcYyacQAZbCkSw31IsaSxqoiogTDhGVbSVQnNpFzCb9xLQFPYC6Cp8nvILM0Nu3N_05zi2zUMJO2Kr3YJksh3yFrN1gahN3ddslT3-a-eHv5Dp4OUAnprKAD-A-1FEkECtYJeCkY15C2ciw6tDAP2g_P2A-A2ilt-VcwijMc2AM9Bv8Wb1bSQcVTsEce2reD6ztWd1tgLpZ8xnzIRJo47aUXipugHXivZiy4U6kxNgMoZDLY3yHOvLDCZorroI33UlgvwTHaJyt5kYdDQi0HzK6DFU6MpfDc6DEv85nKecfj0CTnc-GNQJsxRWHzUHxORwvxNclBtQKjSUW7MUJuQXCG0qM_jD4m6_CuS2xOSCODvRxOyar7AjF_nJVqAs9ur_MDiZrFlA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Randomized+Trial+to+Test+a+Chemo-Mechanical+Antiplaque+Regimen+as+Adjunct+to+Periodontal+Therapy&rft.jtitle=JDR+clinical+and+translational+research&rft.au=Li%2C+L&rft.au=Hayashi-Okada%2C+Y&rft.au=Falkner%2C+K+L&rft.au=Cervi%2C+S&rft.date=2024-04-01&rft.issn=2380-0852&rft.eissn=2380-0852&rft.volume=9&rft.issue=2&rft.spage=160&rft_id=info:doi/10.1177%2F23800844231167065&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2380-0852&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2380-0852&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2380-0852&client=summon